ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

J&J Begins Settlement of Power Morcellator Cancer Lawsuits

lawyer speaks to court jury

Johnson & Johnson is making a move to settle lawsuits filed by women who say the company’s surgical devices called power morcellators spread undetected uterine cancer, The Wall Street Journal reported.

As of March 15, 2016, there are about 31 morcellator lawsuits pending in federal court against J&J’s Ethicon unit before Judge Kathryn H. Vratil in Kansas, according to the Judicial Panel on Multidistrict Litigation. These cases combined with new cases ready to be filed push the number to about 100, WSJ reported.

Women involved in the suits had hysterectomies or uterine fibroid removal with morcellators. Plaintiffs say J&J and Ethicon failed to warn them about the risk that the devices could worsen undiagnosed uterine cancer, making it more difficult to treat. A number of plaintiffs died before or after the lawsuits were filed and attorneys are trying to speed up litigation to allow clients their “day in court.”

By the time the lawsuits are all settled, J&J expects to spend millions. But individual settlements vary depending on the injuries and circumstances of the case. So far, the range of settled cases runs from $100,000 to about $1 million, according to WSJ‘s sources.

While Paul Pennock, plaintiff lawyer and co-lead counsel on the steering committee of the federal power morcellator MDL against Ethicon, praised J&J’s willingness to settle, he is not impressed by the numbers thus far.

“I was surprised to read that cancer cases of dying or deceased women settled for so little, but perhaps all of the settled cases had significant problems,” Pennock told Drugwatch.  “Significant problems, however, are entirely different than issues and concerns.  All cases have issues but that doesn’t mean you settle a client’s case for an amount that is unreasonable.  You take it into account, but the range of the settlements reported in the WSJ suggests that all of those cases had real problems.”

Power morcellators are electric devices with blades that allow surgeons to cut up large pieces of tissue like the uterus or fibroids and remove them through small incisions in the abdomen during minimally invasive surgery. In theory, minimally invasive surgery allows for quicker healing time, less blood loss and fewer complications.

Devices Spark Controversy

Controversy exploded over laparoscopic power morcellators manufactured by Ethicon and several other companies in 2014 after the U.S. Food and Drug Administration released a warning that about 1 in 350 women had an undiagnosed uterine cancer that could be spread by the surgical device. One type of cancer called leiomyosarcoma is especially deadly with a poor prognosis.

After the warning by the FDA in 2014, J&J pulled its devices off the market. The NJ-based pharma giant had the largest chunk of the market.

Lawsuits against J&J and Ethicon claim the devices are defective and that the company knew about the possibility of spreading cancer but failed to warn the public. Ethicon morcellators “have always included cautions in their instructions for use about the potential spread of malignant (or suspected malignant) tissue,” the company previously told WSJ.

While plaintiff’s attorneys see the move towards settlement as a positive development for their clients, not everyone is as positive.

Dr. Hooman Noorchashm, a physician and advocate against morcellators, is concerned that these settlements could gloss over the facts and problems surrounding morcellators.

“Each one of these cases is an opportunity to create a public record about what went wrong — both ethically and at a regulatory level — so nothing like it happens again,” he told the WSJ.

Noorchasm’s wife, Amy Reed, filed her own lawsuit against Karl Storz, another morcellator maker, after she developed uterine cancer after a hysterectomy with the device. The company said it would move to dismiss the lawsuit. The German company previously threatened Noorchashm with legal action to protect its “good name” and “rights.”

J&J Plans to Continue to Settle Claims

According to attorneys, J&J is already in talks to settle more of its morcellator lawsuits, including those it faces in state courts throughout the country.

In the meantime, attorneys expect more cases to be filed. According to court transcripts, plaintiff attorney Sean Tracey said he had “another 40 morcellator cases” ready to be filed.

Pennock commented that other women and their families might still be unaware that a morcellator worsened their cancer and contributed to their death. “Those they left behind have no idea what happened to them,” he told WSJ.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine

2 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Levitz, J. (2016, March 18). Johnson & Johnson Settling Cases Tied to Device That Can Spread Uterine Cancer. The Wall Street Journal. Retrieved from
  2. Wasserman, E. (2016, March 21). UPDATED: J&J moves to settle swath of lawsuits over power morcellator devices: WSJ. Fierce Medical Devices. Retrieved from
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(888) 645-1617